Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenografts
- 1 April 1992
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (4-5) , 767-773
- https://doi.org/10.1016/0959-8049(92)90112-f
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Characterisation and properties of a small cell lung cancer cell line and xenograft WX322 with marked sensitivity to alpha-interferonBritish Journal of Cancer, 1991
- The clonogenic assay with human tumor xenografts: Evaluation, predictive value and application for drug screeningAnnals of Oncology, 1990
- Preclinical phase II study of ifosfamide in human tumour xenografts in vivoCancer Chemotherapy and Pharmacology, 1990
- A new experimental metastasis model in athymic nude mice, the human malignant melanoma loxInternational Journal of Cancer, 1988
- Studies on the pathogenesis of vincristine‐induced neuropathyMuscle & Nerve, 1987
- A phase I study of vinblastine tryptophan esterCancer Chemotherapy and Pharmacology, 1986
- Vinblastin-23-oyl amino acid derivatives: chemistry, physicochemical data, toxicity, and antitumor activities against P388 and L1210 leukemiasJournal of Medicinal Chemistry, 1985
- Neurotoxicity of Commonly Used Antineoplastic AgentsNew England Journal of Medicine, 1974